Imugene Ltd confirms dose escalation in phase 1 trial of new cancer drug CHECKvacc proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Imugene Ltd receives ethical clearance to start US Phase 1 clinical trial proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.
Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protects its.
Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protects its.